Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier

• Emma Bondy-Chorney,

  Affiliation Department of Cellular and Molecular Medicine, University of Ottawa; Centre for Neuromuscular Disease, Ottawa, Ontario, Canada

  ⨯
• Tara E. Crawford Parks,

  Affiliation Department of Cellular and Molecular Medicine, University of Ottawa; Centre for Neuromuscular Disease, Ottawa, Ontario, Canada

  ⨯
• Aymeric Ravel-Chapuis,

  Affiliation Department of Cellular and Molecular Medicine, University of Ottawa; Centre for Neuromuscular Disease, Ottawa, Ontario, Canada

  ⨯
• Roscoe Klinck,

  Affiliation Département de microbiologie et d'infectiologie, Université de Sherbrooke, Sherbrooke, Québec, Canada

  ⨯
• Lynda Rocheleau,

  Affiliation Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• Martin Pelchat,

  Affiliation Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• Benoit Chabot,

  Affiliation Département de microbiologie et d'infectiologie, Université de Sherbrooke, Sherbrooke, Québec, Canada

  ⨯
• Bernard J. Jasmin,

  Affiliation Department of Cellular and Molecular Medicine, University of Ottawa; Centre for Neuromuscular Disease, Ottawa, Ontario, Canada

  ⨯
• Jocelyn Côté

  * E-mail: jcote@uottawa.ca

  Affiliation Department of Cellular and Molecular Medicine, University of Ottawa; Centre for Neuromuscular Disease, Ottawa, Ontario, Canada

  ⨯